Hidradenitis Clinical Trial
Official title:
Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality
The aim of this study is to determine the benefits of group psychotherapy on quality of life for people with hidradenitis suppurativa receiving medical and surgical treatment versus a control group (awaiting group) treated with medical and surgical treatment, without psychotherapy.
Further investigations studies are needed to determine the efficacy of psychological
interventions for people with hidradenitis suppurativa.
The aim of this study is to determine the benefits of group psychotherapy on quality of life
for people with hidradenitis suppurativa receiving medical and surgical treatment versus a
control group (awaiting group) treated with medical and surgical treatment, without
psychotherapy.
This is an experimental randomized trial with control group. Quality of life, symptoms:
pruritus, odor and pain, distress and the illness will be measured before and after the
intervention using psychological and quality of life questionnaires, and dermatological
evaluations for 120 subjects.
The investigators expect that the experimental group scores at the end of the psychotherapy
program will be less than 4 points in Visual Analog Scale (VAS) for pruritus, odor and pain.
The Dermatology Quality of Life Index (DQLI) expected to be less than 4 points from the
initial score, and the patients are expected to present less than 7 points in Hospital
Anxiety and Depression Scale (HADS). The experimental group scores will be less than the
control group for quality of life, symptoms and distress.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03275870 -
Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
|
Phase 1/Phase 2 | |
| Completed |
NCT04449354 -
HidraWear AX HS Study
|
N/A | |
| Recruiting |
NCT06118099 -
Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
|
Phase 2 | |
| Completed |
NCT01352078 -
Wound Etiology and Healing Study
|
||
| Terminated |
NCT03040804 -
Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa
|
N/A | |
| Recruiting |
NCT06374212 -
Anifrolumab for Hidradenitis Suppurativa
|
Phase 2 | |
| Not yet recruiting |
NCT02999698 -
Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
|
N/A | |
| Recruiting |
NCT05989945 -
HIDRAdenitis Suppurativa and HEART Disease
|